FDA and Drug Makers at Odds Over Antibiotics

Omaha.com has an article about the years long dispute between the FDA and drug makers over antibiotics. The main point of contention between the two groups is the testing and approval of new antibiotics. The FDA wants to impose more stringent rules and testing procedures for antibiotics. They want drug makers to show that new antibiotics are better than the old antibiotics. Drug makers are concerned they won't be able to reliably show this and are concerned about the increased costs in research and development this would entail. The FDA's focus on this issue comes from past scandals with approved antibiotics and concerns that with previous testing and approval methods new antibiotics that were worse than the old were being approved because of the margins of success defined.This is an important discussion to keep an eye on. Antibiotics fight bacteria that can cause all sorts of infections and wreak havoc with the human body. Even what might be considered one of the less dangerous infections caused by bacteria, sinusitis, can become deadly if the infection is by antibiotic resistant bacteria. Without new antibiotics and with resistant bacteria appearing more and more the lack of movement to create new and effective antibiotics to fight infection could exacerbate the issue and create a crisis. For more information about antibiotics and sinusitis treatment, contact our office for an appointment.